Ghana vs Malaysia: Antiretroviral therapy coverage for PMTCT
Ghana
99.0%
in 2024
Malaysia
99.0%
in 2024
Ghana rank
5th
Malaysia rank
5th
Antiretroviral therapy coverage for PMTCT over time
- Ghana
- Malaysia
How they compare
Ghana currently reports 99.0% against 99.0% in Malaysia, a difference of 0.0%.
Across all 25 years both countries report, Malaysia has been ahead every year.
Ghana ranks 5th and Malaysia ranks 5th of 84 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.6% | 86.7% | 77.1% | Malaysia |
| 2010s | 59.9% | 77.3% | 17.4% | Malaysia |
| 2020s | 89.0% | 98.0% | 9.0% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ghana or Malaysia?
- Ghana, at 99.0% against 99.0% in Malaysia as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ghana and Malaysia?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Malaysia?
- 25 years are reported by both, from 2000 to 2024.
- How do Ghana and Malaysia rank globally for antiretroviral therapy coverage for pmtct?
- Ghana ranks 5th and Malaysia ranks 5th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).